Opioid Vaccine: Nanoparticle Breakthrough vs Crisis | AcademicJobs
Explore Virginia Tech's hybrid nanoparticle vaccine combating the opioid crisis by blocking oxycodone and fentanyl effects. Preclinical success promises reduced overdoses and relapse.

